THERAPEUTIC AREA PORTFOLIO · 31 PRODUCTS
Immunology & Inflammation
Catalog programs in this area include JAK and TYK2 pathway modulators, immune-mediated dermatology candidates, inflammatory-disease programs and other targeted approaches to immune regulation.
Target APIs & Active Pipeline Programs in Immunology & Inflammation
Immunology & Inflammation Products (31)
Catalog products related to terminal APIs in this area.
CP-RUXO-01CAS 1146629-84-6
(R)-3-cyclopentyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propanenitrileTarget API: Ruxolitinib
CP-BARI-01CAS 1187595-85-2
2-(1-(Ethylsulfonyl)azetidin-3-ylidene) acetonitrileTarget API: Baricitinib
CP-BARI-02CAS 1029716-44-6
1-(1-Ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazoleTarget API: Baricitinib / Ruxolitinib
CP-TOFA-03CAS 941685-26-3
4-Chloro-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-D] pyrimidineTarget API: Baricitinib / Tofacitinib
CP-BELU-03CAS 2121561-39-3
N-isopropyl-2-(3-(4-oxo-3,4-dihydroquinazolin-2-yl)phenoxy)acetamideTarget API: Belumosudil
CP-TOFA-01CAS 1062580-52-2
(3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochlorideTarget API: Tofacitinib
CP-TOFA-06CAS 1228879-37-5
1-Benzyl-N,4-dimethylpiperidin-3-aminedihydrochlorideTarget API: Tofacitinib
CP-TOFA-05CAS 477600-74-1
N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amineTarget API: Tofacitinib
CP-UPAD-01CAS 1428243-26-8
(3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidine carboxylic acid phenylmethyl esterTarget API: Upadacitinib
CP-UPAD-02CAS 1201187-44-1
tert-butyl 5-tosyl-5H-pyrrolo[2,3-b]pyrazin-2-ylcarbamateTarget API: Upadacitinib
CP-BREN-01CAS 1273567-44-4
(S)-4-(tert-butoxycarbonyl)-1,4-oxazepane-2-carboxylic acidTarget API: Brensocatib
CP-BREN-02CAS 1159489-37-8
(S)-tert-butyl (1-cyano-2-(4-iodophenyl)ethyl)carbamateTarget API: Brensocatib